Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC)

Bone Marrow Transplant. 1989 Jan:4 Suppl 1:86-9.

Authors

S C Gulati¹, J Gaynor, I Esseesse, T Gee, C Little, M Andreeff, E Berman, S Kempin, B Clarkson

Affiliation

¹ Memorial Sloan-Kettering Cancer Center, New York, NY.

PMID: 2653525

No abstract available

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow Transplantation
Combined Modality Therapy
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Prognosis
Regression Analysis
Remission Induction
Risk Factors